COVID-19 Vaccine Using Rhabdovirus Vector – Funded By DBT The global
response to the unprecedented COVID-19 pandemic is drawing on the
lessons learned from other disease outbreaks in the past. The
development of a COVID-19 vaccine must balance manufacturing speed and
technical feasibility with clinical safety and immunogenicity trial
outcomes, in the setting of a […]
The post DBT's National Pharma Mission To Fund COVID-19 Vaccine
Project appeared first on BioTecNika .
https://www.biotecnika.org/2020/06/covid-19-vaccine-using-rhabdovirus-vector-funded-by-dbt/
Biotech News
No comments:
Post a Comment